The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Targeting advanced pancreatic cancer with activated t cells armed with anti-CD3 x anti-EGFR bispecific antibody.
 
Lawrence G. Lum
Stock and Other Ownership Interests - TransTarget
Consulting or Advisory Role - Rapa Therapeutics
Patents, Royalties, Other Intellectual Property - TransTarget
 
Minsig Choi
No Relationships to Disclose
 
Tri Minh Le
No Relationships to Disclose
 
Archana Thakur
No Relationships to Disclose
 
Abhinav Deol
No Relationships to Disclose
 
Karen K. Ballen
No Relationships to Disclose
 
Leonid Volodin
No Relationships to Disclose
 
Tamila L. Kindwall-Keller
No Relationships to Disclose
 
Qin Liu
No Relationships to Disclose
 
Gregory Dyson
No Relationships to Disclose
 
Anthony Frank Shields
Employment - Benchling (I)
Stock and Other Ownership Interests - Benchling (I)
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Endocyte; GE Healthcare; Merck; Merrimack; Personal Genome Diagnostics; Siemens Healthcare Diagnostics; Taiho Pharmaceutical
Speakers' Bureau - GE Healthcare
Research Funding - Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Caris Life Sciences; Eisai; H3 Biomedicine; Inovio Pharmaceuticals; Karyopharm Therapeutics; Merrimack; Novartis; OncoMed; Plexxikon; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Caris Life Sciences; Endocyte; GE Healthcare; Merrimack